Table 4.
Descriptive statistics of the whole population according to early prosthetic infection presence
| Variable | MD (n) | EPI group, mean±s.d. or n (%) | Non-EPI group, mean±s.d. or n (%) | P |
|---|---|---|---|---|
| Age | 0 | 58.4±10.4 | 60.8±9.4 | 0.145 |
| ASA score >2 | 274 | 10 (35.9) | 84 (31.1) | 0.618 |
| TS/exTS | 0 | 24 (68.6) | 330 (61.8) | 0.423 |
| Obesity (BMI >30 kg m−2) | 10 | 11 (31.4) | 136 (25.8) | 0.464 |
| Diabetes | 0 | 22 (62.8) | 220 (41.8) | 0.012* |
| HT | 11 | 22 (66.6) | 319 (60.5) | 0.483 |
| Dyslipidemia | 6 | 17 (48.6) | 240 (45.4) | 0.720 |
| Cardiopathy | 2 | 7 (20.0) | 99 (18.6) | 0.838 |
| Hypogonadism | 0 | 0 (0) | 11 (2.1) | – |
| Spinal cord injury | 0 | 1 (2.9) | 4 (0.7) | 0.273 |
| Immunosuppression | 0 | 1 (2.9) | 11 (2.8) | 1 |
| Previous pelvic surgery | 0 | 8 (22.9) | 170 (31.8) | 0.267 |
| Previous pelvic radiotherapy | 0 | 0 (0) | 26 (4.9) | 0.395 |
| Peyronie’s disease | 1 | 6 (17.1) | 98 (18.4) | 0.854 |
| Contextual Peyronie’s surgery | 0 | 3 (8.6) | 39 (7.3) | 0.737 |
| Priapism | 0 | 1 (2.9) | 11 (0.2) | 0.539 |
| Contextual urinary sphincter/urethral sling implantation | 0 | 0 (0) | 4 (0.7) | – |
| Postoperative antibiotic: amoxicillin clavulanate | 52 | 22 (73.3) | 277 (56.5) | 0.071 |
| Postoperative antibiotic: ciprofloxacin | 52 | 5 (16.7) | 191 (39.0) | 0.014* |
| Operation time | 0 | 95.3±31.7 | 85.5±28.9 | 0.032* |
| LVI | 2 | 10 (28.6) | 105 (19.7) | 0.204 |
| r/g-c 3IPP | 5 | 20 (58.8) | 205 (38.5) | 0.019* |
| Redo surgery | 0 | 8 (22.9) | 57 (10.7) | 0.048* |
| Drainage | 11 | 16 (47.1) | 264 (49.9) | 0.782 |
*P value according to the Mann-Whitney U test or the Fisher’s exact test as indicated. EPI: early prosthetic infection; MD: missing data; s.d.: standard deviation; ASA: American Society of Anesthesiologists; TS: tobacco smoker; BMI: body mass index; HT: hypertension; LVI: surgeon in training/low-volume implanter; r/g-c 3IPP: rifampin/gentamicin-coated 3-piece inflatable penile prosthesis; exTS: former tobacco smoker; –: not available